Question 1

How many shares of GANX does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 274,957 shares of GANX (GAIN THERAPEUTICS INC).

Question 2

What is BlackRock, Inc.'s GANX position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s GANX position is worth $558,163.

Question 3

Is BlackRock, Inc. buying or selling GANX?

Accepted Answer

In 2026-Q2, BlackRock, Inc. increased their GANX position (+22.2% change in shares).

Question 4

When did BlackRock, Inc. first buy GANX?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in GANX in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	274,957	+22.2%	$558,163	0.0%	$2.03	20
2026-Q1	Increased	225,046	+7.4%	$436,589	0.0%	$2.63	18
2025-Q4	Increased	209,579	+80.4%	$674,844	0.0%	$3.05	26
2025-Q3	Increased	116,184	+3.3%	$205,646	0.0%	$1.81	16
2025-Q2	Increased	112,507	+33.3%	$202,512	0.0%	$1.97	20
2025-Q1	Decreased	84,407	-1.9%	$161,218	0.0%	$1.89	0
2024-Q4	New	86,061	-	$185,892	0.0%	$2.18	35

GANX7 quarters

GANX
7 quarters